You are here

Heparin Market is Expected to Accumulate Revenues Worth US$16.3 Billion by 2025 - TMR

ALBANY, New York, Aug. 14, 2019 /PRNewswire/ -- The global Heparin Market is prognosticated to witness a substantial growth at 6.2% of CAGR over the forecast period 2017 to 2025, finds the forthcoming report by Transparency Market Research (TMR).

The global heparin market registered revenue worth US$ 10.1 bn in 2017 and it is foretold to stand tall at an estimated value of US$ 16.3 bn by 2025. Rising occurrence of venous thrombosis due to various underlying factors such as cardiovascular diseases are expected to boost the sales of heparin. As a result, the global heparin market is expected to grow at a healthy rate.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=803

Rising Number of Surgeries to Strengthen Heparin Market

The number of patients undergoing surgeries is many and major surgeries such as orthopedic, heart surgeries may need heparin to prevent life threatening deep vein thrombosis. This is expected to surge the global heparin market during the forecast period.

Patients who are already on anticoagulants such as warfarin are asked to stop the use few days before the surgery. Instead they are put on heparin which is a mild anticoagulant to prevent excessive bleeding. This could lead to the expansion of the heparin market. However, it is important to note that even heparin is stopped few hours before the surgery and restarted a couple of hours after the surgery. This is a common practice that the surgeons follow in heart patients or patients requiring continuous anticoagulants. This may lead to substantial growth of the global heparin market.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

Heparin is also used in orthopedic surgeries, this is because whether the patient has heart issues or not, these surgeries lead to immobility for a longer time. Surgeries such as knee replacements, hip replacements, any kind of arthoplasty where the patient lies idle for a few days are administered heparin to prevent deep vein thrombosis. It is only stopped when the patient regains full mobility after a couple of months. These factors might aid in the grand growth of the global heparin market.

According to the new study, on an average 340,000 Coronary Artery Bypass Grafting are done in the U.S. alone. Also, the study states that 1.6 million knee and hip replacements took place in 2017, in the U. S. These figures are a positive sign that indicate a grand growth in the global heparin market in the upcoming years.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=803

Heparin is not advised to patients undergoing neurosurgery due to the fear of postoperative complications, which may hinder the growth of the global heparin market over the forecast period. Nonetheless, the use of heparin during blood transfusion and blood sampling may boost the global heparin market in the upcoming years.

North America to Intensify Global Heparin Market

North America leads the heparin market and is expected to continue its dominance over the global heparin market during the forecast period. The growth can be due to increasing geriatric population, rising number of venous thrombosis disorder, and growing number of heart surgeries.

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=803

Asia Pacific is expected to emerge as a lucrative market over the forecast period. This is because of increasing population with venous thrombosis and pulmonary embolism (PE). Deep vein thrombosis is becoming common in Asia Pacific, especially in India. According to national institute of health DVT without PE, DVT with PE, and PE alone constitute 64% in all. This could result in the increased sales of heparin in the global heparin market.

A few major players in the global heparin market include LEO Pharma A/S, Dr. Reddy's Laboratories Ltd., Sanofi, Pfizer, Inc., Aspen, Baxter International Inc., and Syntex S.A.

This review is based on the findings of a TMR report titled, "Heparin Market (Product - Unfractionated Heparin (UFH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH); Source - Bovine and Porcine; Formulation - Oral and Parenteral)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017- 2025."

Popular Research Reports by TMR:

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: +866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Research Blog: https://tmrblog.com/ 

Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg